Intrinsic value of BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX)
Live fair value data for BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX) is currently unavailable. Please check again shortly.
Current Price: $161.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX) undervalued or overvalued?
Based on the current model output, BlackRock Health Sciences Opportunities Portfolio Investor A Shares appears to be undervalued with a upside of 64.00%.
Fair value vs market price — BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX)
Unlock premium access to view the live fair value comparison against current market price for SHSAX.
Frequently Asked Questions - SHSAX
How is SHSAX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for SHSAX.
Is SHSAX undervalued or overvalued right now?
SHSAX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for SHSAX: open their intrinsic value pages.
- FSPHXFidelity Select Health Care Portfolio
- LMGNXClearBridge International Growth I
- AAgilent Technologies, Inc.
- TWHIXAmerican Century Heritage Investor Class
- SSentinelOne, Inc.
- SHSSXBlackRock Health Sciences Opportunities Portfolio Institutional Shares
- RBAIXT. Rowe Price Balanced I Class
- SHSKXBlackRock Health Sciences Opportunities Portfolio Class K